ClinicalTrialsFinder

Gangliosidoses, GM2 Clinical Trials in Calgary, Alberta

1 recruitingCalgary, Alberta, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

Gangliosidoses, GM2Gangliosidosis, GM1
Azafaros A.G.75 enrolled36 locationsNCT07082543